Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 4 Issue 6

The Effect of Mitomycin-C Application Time on Pterygium Recurrence After Surgical Excision

Pir Salim Mahar1*, Abdul Sami Memon2 and Israr Ahmed Bhutto3

1Professor of Ophthalmology and Dean, Isra Postgraduate Institute of Ophthalmology, Professor and Section Head, Director Glaucoma Service, Aga Khan University Hospital, Karachi, Pakistan
2Assistant Professor, Isra Postgraduate Institute of Ophthalmology, Aga Khan University Hospital, Karachi, Pakistan
3Associate Professor, Isra Postgraduate Institute of Ophthalmology, Karachi, Pakistan

*Corresponding Author: Pir Salim Mahar, rofessor of Ophthalmology and Dean, Isra Postgraduate Institute of Ophthalmology, Professor and Section Head, Director Glaucoma Service, Aga Khan University Hospital, Karachi, Pakistan.

Received: May 04, 2021; Published: May 11, 2021

×

Abstract

Objective: The purpose of the study was to establish the safest and the most efficacious duration of application of MMC in patients undergoing primary pterygium excision to prevent recurrence.

Methods: An interventional study was carried out at Isra Postgraduate Institute of Ophthalmology/Al-Ibrahim Eye Hospital, Karachi, Pakistan from 2010 till 2017. Patients underwent surgical removal of pterygium using bare sclera method with MMC in concentration of 0.2 mg/ml (0.02%) with variable exposure time of 1 - 5 minutes. Classification of patients was done randomly with MMC application time ranging from 1 to 5 minutes. Patients were followed at 3, 6, 9 and 12 months postoperatively to record any recurrence.

Results: A total 273 eyes of male patients with mean age of 35.9 ± 1.23 years were included in the study. The overall pterygium recurrence rate at each follow-up was 5.66%, 6.92%, 7.90% and 9.3% at 3rd, 6th, 9th and 12th months respectively. There was a significant decline in recurrence in the number of patients with MMC application time of greater than 3 minutes at all follow-ups. Maximum of recurrence was seen in patients between 31 to 40 years at the final follow-up.

Conclusion: These results suggest that a MMC application time of less than 3 minutes increases the chances of pterygium recurrence after surgical excision. MMC application time of greater than 3 minutes is recommended to prevent recurrence of such high risk recurrent pathology.

Keywords: Pterygium; Recurrence; Mitomycin-C; Duration

×

References

  1. Rezvan F., et al. “Prevalence and risk factors of pterygium: a systematic review and meta-analysis”. Survey of Ophthalmology 3 (2018): 719-734.
  2. Ang M., et al. “Prevalence of and racial differences in pterygium: a multiethnic population study in Asians”. Ophthalmology 8 (2012): 1509-1515.
  3. Bradley JC., et al. “The science of pterygia”. British Journal of Ophthalmology 7 (2010): 815-820.
  4. Hirst LW. “The treatment of pterygium”. Survey of Ophthalmology2 (2003): 145-180.
  5. D'Ombrain A. “THE SURGICAL TREATMENT OF PTERYGIUM”. British Journal of Ophthalmology2 (1948): 65-71.
  6. Frucht-Pery J., et al. “Intraoperative application of topical mitomycin C for pterygium surgery”. Ophthalmology4 (1996): 674-677.
  7. Singh G., et al. “Mitomycin eye drops as treatment for pterygium”. Ophthalmology6 (1988): 813-821.
  8. Kunitomo N and Mori S. “Studies on the pterygium. Part 4. A treatment of the pterygium by Mitomycin C instillation”. The Japanese Journal of Ophthalmology 67 (1963): 601-607.
  9. Mahar PS and Nwokora GE. “Role of Mitomycin C in pterygium surgery”. British Journal of Ophthalmology 77 (1993): 433-435.
  10. Avistar R., et al. “Intraoperative Mitomycin C 0.02% for pterygium: effect of duration of application on recurrence rate”. Cornea 22 (2003): 102-104.
  11. Koranyi G., et al. “Intraoperative Mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up”. Acta Ophthalmologica 90 (2012): 266-270.
  12. Young AL., et al. “Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery”. Ophthalmology12 (2013): 2390-2395.
  13. Hata T., et al. “Mitomycin, a new antibiotic from Streptomyces I”. Antibiot4 (1956): 141-146.
  14. Mahar PS., et al. “The effect of sub-conjuctival Mitomycin C on intraocular pressure in various types of glaucoma”. Asian Journal of Ophthalmology 12 (2010): 2-6.
  15. Oguz H., et al. “Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery”. Acta Ophthalmologica Scandinavica2 (1999): 147-150.
  16. Liang QF., et al. “Epidemiology of pterygium in aged rural population of Beijing, China”. Chinese Medical Journal 13 (2010): 1699-1701.
  17. Gazzard G., et al. “Pterygium in Indonesia: Prevalence, severity and risk factors”. British Journal of Ophthalmology12 (2002): 1341-1346.
  18. Hayasaka S., et al. “Postoperative instillation of low dose Mitomycin C in the treatment of primary pterygium”. American Journal of Ophthalmology 106 (1988): 715-718.
  19. Rachimiel R., et al. “Results of treatment with topical Mitomycin C 0.02% following excision of primary pterygium”. British Journal of Ophthalmology 79 (1995): 233-239.
  20. Hashemi H., et al. “The prevalence and determinants of Pterygium in rural areas”. Journal of Current Ophthalmology 3 (2017): 194-198.
  21. Rahman A., et al. “Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C”. Journal of College of Physicians and Surgeons Pakistan8 (2008): 489-492.
  22. Cheng HC., et al. “Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery”. Cornea1 (2001): 24-29.
  23. Chen PP., et al. “A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium”. American Journal of Ophthalmology 2 (1995): 151-160.
  24. Mastropasqua L., et al. “Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium”. British Journal of Ophthalmology 4 (1996): 288-291.
  25. Kareem AA., et al. “The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium”. Clinical Ophthalmology 6 (2012): 1849-1854.
  26. Robin AL., et al. “A long-term dose-response study of mitomycin in glaucoma filtration surgery”. Archives of Ophthalmology 8 (1997): 969-974.
  27. Lam DS., et al. “Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study”. Ophthalmology5 (1998): 901-904.
  28. Shah SI., et al. “Factors associated with pterygium based on history and clinical examination of patients in Pakistan”. Journal of Current Ophthalmology 2 (2016): 91-92.
×

Citation

Citation: Pir Salim Mahar., et al. “The Effect of Mitomycin-C Application Time on Pterygium Recurrence After Surgical Excision".Acta Scientific Ophthalmology 4.6 (2021): 21-26.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US